SPMC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Price action and momentum are bearish (downtrend with weakening momentum), short-term pattern stats point to further downside over the next week/month, and heavy insider selling is a major negative. With earnings approaching in mid-February, risk is skewed toward an unfavorable entry for an impatient buyer.
Trend/momentum is bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), showing a sustained downtrend. MACD histogram is negative (-0.0131) and expanding lower, suggesting downside momentum is strengthening rather than stabilizing. RSI(6) ~30.4 is near oversold but not showing a clear reversal signal. Key levels: pivot 14.168 (price below pivot is bearish), resistance 14.416 then 14.569; support 13.919 then 13.766—if 13.77 breaks, downside can accelerate. Pattern-based forecast is also negative: ~80% chance of -1.07% next day, -4.06% next week, -3.53% next month.
Intellectia Proprietary Trading Signals
Upcoming earnings/conference call in mid-February could reset expectations if results beat; Street still has Buy ratings with price targets materially above the current price (~$13.91), implying perceived undervaluation if fundamentals stabilize.
Insiders are Selling with selling amount up ~8959% over the last month (strong negative sentiment signal). Technicals are in a clear downtrend (bearish MA stack + negative/expanding MACD). Analyst price targets have been cut recently (multiple downward revisions). Near-term event risk: earnings in mid-February could disappoint given the recent note about net interest income coming in below some estimates.
Financial snapshot data was not available (error provided: list index out of range), so a quarter-by-quarter growth assessment cannot be completed from the dataset. The next reported season is QDEC 2025 earnings (est. EPS ~0.55) scheduled pre-market in mid-February, which increases event-driven risk near term.
Recent analyst stance remains Buy, but the trend is clearly toward lower price targets: B. Riley cut PT to $16 from $23 (Buy), Alliance Global cut to $18.50 from $20 (Buy) after quarterly results where net interest income missed their estimate, and Clear Street cut to $18 from $20 (Buy). Wall Street pros: still bullish ratings and targets above market suggest upside if credit metrics and net interest income hold up. Cons: repeated target cuts indicate deteriorating confidence/expectations, and recent results commentary implies performance is not consistently meeting estimates.
